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20S proteasome, which also forms the core of the 26SMatthew Bogyo,* Hans J.Geuze,³ and Hidde L. Ploegh*
*Center for Cancer Research (1500 kDa) proteasomal complex that degrades ubiqui-
tin-conjugated proteins in an ATP-dependent manner.Department of Biology
Massachusetts Institute of Technology Nonubiquitinated proteins can also be degraded by the
proteasomal complex. The resultant peptides enter theCambridge, Massachusetts 02139
²Department of Molecular Biology ER through a dedicated peptide transporter, the TAP
(transporter associated with antigen processing) com-Infectious Diseases Section
Wyeth±Ayerst Research plex (Heemels and Ploegh, 1995).
Down-regulation of class Imolecules in virally infectedPearl River, New York 10965
³Department of Cell Biology or transformed cells is a well-established phenomenon
and often involves attenuation of transcription of theUtrecht University School of Medicine
Utrecht genes encoding the class I subunits (Maudsley and
Pound, 1991). In addition, posttranscriptional mecha-The Netherlands
nisms of down-regulation have been described and in-
clude the production of proteins that mediate retention
of newly synthesized class I molecules in the ER. SuchSummary
is the case for those strains of adenovirus that express
the E3 19K protein (Burgert and Kvist, 1985), and thisHuman cytomegalovirus (HCMV) down-regulates ex-
may also apply to mouse cytomegalovirus-infectedpression of MHC class I products by selective proteo-
cells, where ER retention of class I molecules has beenlysis. A single HCMV gene, US11, which encodes an
observed (del Val et al., 1992). In both cases, the ER-endoplasmic reticulum (ER) resident type-I transmem-
retained class I molecules are relatively stable and per-brane glycoprotein, is sufficient to cause this effect.
sist for hours. More recently, it was shown that the Her-In US111 cells, MHC class I molecules are core-glyco-
pes simplex viruses 1 and 2 produce a small cytosolicsylated and therefore inserted into the ER. They are
protein, called ICP47, that blocks class I cell surfacedegraded with a half-time of less than 1 min. A full-
expression (York et al., 1994) by inactivating the TAPlength breakdown intermediate that has lost the single
peptide transporter (FruÈ h et al., 1995; Hill et al., 1995).N-linked glycan in an N-glycanase-catalyzed reaction
By denying access of cytosolic peptides to the lumentransiently accumulates in cells exposed to the prote-
of the ER, ICP47 prohibits stable assembly of class Iase inhibitors LLnL, Cbz-LLL, and lactacystin, identi-
molecules and prevents their expression at the cellfying the proteasome as a key protease. Subcellular
surface.fractionation experiments show this intermediate to
A different member of the herpes virus family, humanbe cytosolic. Thus, US11 dislocates newly synthesized
cytomegalovirus (HCMV), is also known to down-regu-class I molecules from the ER to the cytosol, where
late expression of class I molecules, but apparently doesthey are acted upon by an N-glycanase and the pro-
so through rapid destruction of newly synthesized classteasome.
I molecules (Beersma et al., 1993; Jones et al., 1995).
We here describe experiments to show that the US11Introduction
gene product encoded by HCMV has the highly unusual
property of being able to deliver class I heavy chainsCytolytic T cells play a role in the elimination of virally
from the ER to a cytosolic environment, where theyinfected host cells, and these cells require major histo-
are exposed to N-glycanase and proteasomes to becompatibility complex (MHC) class I molecules to guide
destroyed.the attack (Townsend and Bodmer, 1989). A number of
viruses are capable of manipulating the expression of
the glycoproteins, the MHC class I products, that signal Results
the presence of a virally infected cell to the immune
system (Maudsley and Pound, 1991; Hill and Ploegh, Class I Molecules Are Unstable in US111 Cells
The human astrocytoma cell line U373-MG transfected1995). A priori, every single step of the biosynthesis of
MHC class I products is fair game for the virus. with the US11 gene shows reduced levels of class I
expression at the cell surface (Jones et al., 1995). InClass I molecules consist of two protein subunits, the
MHC-encoded glycoprotein heavy chain, and a small HCMV-infected fibroblasts, we observed rapid destruc-
tion of newly synthesized class I molecules (Beersmasoluble polypeptide, b2-microglobulin (b2m). The short
peptides that are presented by class I molecules fulfill et al., 1993), an observation that was confirmed for the
US11 transfectants. The rapidity of this destruction isan essential structural role and contribute to the forma-
tion of stable class I complexes (reviewed by Heemels apparent from an experiment in which US111 cells were
pulse labeled for 60 s, followed by a chase up to 40 minand Ploegh, 1995). These peptides, 8±10 residues in
length, are derived largely from cytosolic proteins, bro- (Figure 1A). The amount of labeled class I heavy chains
increases between the 0 and 1 min chase points (Figureken down by cytosolic proteases, amongst which the
proteasome is the major proteolytic activity (Rivett, 1A, lanes 1 and 2),which we attribute to the time required
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the Golgi area, cell surface, and nucleus did not exceed
background levels (n 5 20 cells).
Leucyl-leucyl-norleucinal Inhibits a Protease
Involved in Class I Breakdown in US111
Cells and Leads to Accumulation of a
40 kDa Breakdown Intermediate
When cells were exposed to brefeldin A (BFA) to impede
trafficking from the ER to the Golgi, no effect on the half
life of class I heavy chains was seen in US111 cells
(Figure 3). We observe a slight increase (Figure 3A, com-Figure 1. The Half-Life of Class I Heavy Chains in US111 Cells Is
Less than 1 Minute pare lanes 2 and 4 with lanes 6 and 8) in assembled
class I complexes, as detected by the W6/32 antibody(A) Free class I heavy chains were immunoprecipitated with rabbit
serum raised against the luminal domain of class I molecules (anti± in US111 cells exposed to BFA. Because BFA impedes
heavy chain serum). US111 cells were pulse labeled with [35S]methio- the flow of any free b2m from ER to Golgi, the local
nine for 60 s, and chased as indicated, at 378C (lanes 1±7) or 268C increase in the concentration of b2m is expected to favor(lanes 8±14). The immunoprecipitates were separated on a 12.5%
complex formation. We conclude that transfer from theSDS±polyacrylamide gel and visualized by fluorography.
site of synthesis to a compartment distal to the block(B) Class I heavy chain±b2m complexes were immunoprecipitated
in trafficking imposed by BFA is not likely to be requiredwith the monoclonal antibody W6/32; otherwise as A.
(C) Transferrin receptor was precipitated with the monoclonal anti- for destruction of class I molecules in US111 cells.
body 66Ig10; otherwise as A. The calpain I inhibitor leucyl-leucyl-norleucinal (LLnL)
but not the calpain II inhibitor leucyl-leucyl-methional
(data not shown) slowed down the disappearance of
class I heavy chains in US111 cells (Figure 3). Its applica-for equilibration of intracellular methionine and methio-
tion resulted in the transient accumulation of an interme-nyl tRNA pools at these short pulses, and the time re-
diate of lower molecular mass (40 kDa). The breakdownquired for completion of the polypeptide chain. From 1
intermediate, to be further characterized below, wasto 2 min, over half of the radioactivity in the class I heavy
never observed in a complex with b2m, and was unreac-chains is lost (lanes 2, 3), and beyond 20 min of chase,
tive with the W6/32 antibody specific for the assembledno heavy chains remain. This rapid disappearance can-
complex (Figure 3A, compare lanes 4 and 8 with 12 andnot be counteracted by a reduction of temperature: at
16). Application of LLnL to control cells (Figure 3B) failed268C (Figure 1A, lanes 8±14) or 168C (data not shown),
to produce this breakdown intermediate. When un-we observed neither cessation of breakdown, nor the
transfected cells were treated with LLnL or BFA, classaccumulation of breakdown intermediates. Kinetics of
I molecules, both assembled (W6/32 reactive) and freelabeling and destruction of heavy chains, not surpris-
heavy chains, were essentially stable over the 20 miningly, were slower at the reduced temperatures. We con-
chase period (Figure 3B), during which class I heavyclude that breakdown of class Iheavy chains takes place
chains are destroyed completely in US111 cells. Thereprior to their transport from the ER to the Golgi. Given
appeared to be a modest effect of LLnL on the genera-the kinetics with which destruction occurs, the process
tion of W6/32 reactive assembled complexes (Figureis likely to be initiated immediately upon completion of
3B, compare lanes 2 and 4), possibly owing to inhibitorythe polypeptide chain. In cells that do not express US11,
effects of LLnL on proteasomal protein breakdownthe class I heavy chains are stable over the time course
(Rock et al., 1994). We also observed a slight reductionobserved here (Beersma et al., 1993; Jones et al., 1995;
of free heavy chains in BFA-treated cells (Figure 3B,see also Figure 3B).
compare lanes 8 and 12), which may be attributable toClass I heavy chain-b2m complexes can be recovered
increased complex formation as a result of a higherby immunoprecipitation with the monoclonal antibody
concentration of b2m in the ER.W6/32, whereas the rabbit anti±heavy chain serum used
here is specific for free class I heavy chains (Stam et
al., 1986). Both W6/32-reactive and anti±heavy chain- The Light Chain, b2m Is Stable and Secretedreactive class I molecules are stable in control U373- in Increased Amounts in US111 Cells
MG cells (Jones et al., 1995; see below), whereas both Owing to the lack of heavy chains with which b2m canpopulations of class I molecule rapidly disappear from pair (Figures 1 and 3; see the later time points), the
US111 cells (Figures1A and 1B). The transferrin receptor excess of free b2m in US111 cells behaves as a secretory
(Figure 1C) (Beersma et al., 1993; Jones et al., 1995) protein and can be recovered from the supernate in
does not show more rapid decay over the period of increased amounts compared with control cells (Figure
observation in US111 cells than is seen in control cells.
4, compare lanes 2 and 6). Inclusion of the inhibitor LLnL
has no effect on the quantity of b2m released (Figure 4,
lanes 2 and 4). Increased survival of class I heavy chainsUS11 Is an ER-Resident Protein
We performed immunoelectron microscopy on ultrathin in the form of the 40 kDa breakdown intermediate in-
duced by LLnL does not promote association with b2mcryosections of US111 cells and their untransfected
counterparts. The rabbit anti-US11 antibody gave es- and an attendant reduction in the amount of b2m se-
creted. Association of class I heavy chains with b2msentially no labeling on the untransfected cells (Figure
2A). In US111 cells, US11 immunoreactivity was de- in the course of biosynthesis is a very rapid process
(Heemels and Ploegh, 1995). Therefore the US11 genetected exclusively in the ER (Figure 2B). Labeling over
ER to Cytosol Dislocation of Class I Heavy Chains
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Figure 2. US11 is an ER-Resident Protein
Electron micrographs of ultrathin cryosections from a control cell (A) and a US11 transfected cell (B). The sections were immunogold labeled
for US11 with 10 nm gold particles as indicated. In the control cell, two background gold particles can be seen; while in the US11 transfected
cell, US11 is present in the ER (26/28 gold particles over the ER). L, lysosome; M, mitochondrion; P, plasma membrane. Bars, 0.2 mm.
product renders class I heavy chains less capable of intermediate of the observed mobility, and proteolysis of
the COOH-terminal cytoplasmic tail is a rather frequentassociating with b2m, either by altering the conformation
of these heavy chains, or by transferring the heavy chain occurrence for class I molecules. Surprisingly, antibod-
breakdown intermediate to a compartment where asso- ies raised against a synthetic peptide (SDSAQGSDVSL
ciation with b2m can no longer take place. TA) derived from the cytoplasmic COOH terminus of
human class I molecules still recognized the breakdown
intermediate, indicating its COOH terminus was largely,The Class I Breakdown Intermediate in US111
Cells Is Resistant to Endoglycosidase H if not entirely, intact (data not shown). We next consid-
ered other modifications of the class I heavy chain andUpon observation of the40 kDa breakdown intermediate
in LLnL-treated US111 cells, we first considered the performed pulse-chase experiments in conjunction with
digestion using theenzyme endoglycosidase H (endo H).possibility of a proteolytic cleavage removing the cyto-
plasmic tail. Removal of this fragment would produce an Endo H cleaves high mannose±type oligosaccharides as
Cell
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Figure 5. The Class I Breakdown Intermediate in US111 Cells Is
Resistant to Endoglycosidase H
Figure 3. LLnL, but not BFA, Induces a Class I Breakdown Interme- Control cells and US111 cells were preincubated in methionine-free
diate in US111 Cells medium without (minus) or with LLnL or BFA for 1 hr. Cells were
labeled for 15 min with [35S]methionine and chased for 20 min. Class(A) Class I molecules were immunoprecipitated from US111 cells
I molecules were immunoprecipitated with W6/32 and rabbit anti±using the monoclonal antibody W6/32 (lanes 1±8), and rabbit heavy
heavy chain serum. Samples were analyzed by SDS±PAGE beforechain serum (lanes 9±16). The cells were pretreated with the appro-
and after digestion with endoglycosidase H (indicated as minus andpriate inhibitors for 60 min, pulse labeled with [35S]methionine for
plus Endo H). W6/32 precipitates from control cells are shown in15 min, and chased for 20 min. The proteins were separated on a
panel A. W6/32 and anti±heavy chain precipitates from US111 cells12.5% acrylamide gel. The positions of migration of core-glycosy-
are shown in (B), lanes 1±8. Lanes 9±12: anti±heavy chain serumlated class I heavy chain (43±44 kDa; HC) and the breakdown inter-
precipitates from the control cells. Note the endo H resistance ofmediate (z40 kDa; HC with asterisk) are indicated.
the breakdown intermediate (compare lanes 5 and 6 with 7 and 8).(B) Class I molecules were precipitated from control cells using the
monoclonal antibody W6/32 (lanes 1±6), and rabbit anti±heavy chain
serum (lanes 7±12). The cells were pulse labeled with [35S]methionine
for 15 min and chased for 20 min. One hour prior to the pulse-chase in retention of full endo H sensitivity (Figure 5A, compare
experiment, the cells were incubated in methionine-free medium lanes 10 and 12). For US111 cells, only minor amounts
without (minus) or with LLnL or BFA. of assembled W6/32 reactive complexes are detected
(Figure 5B, lanes 1 and 2), almost all of which have
disappeared by 20 min of chase (Figure 5B, lanes 3 andcommonly found onER-resident N-linked glycoproteins.
4; see also Figure 1). In US111 cells exposed to LLnL,Figure 5A shows recovery of class I complexes using
we observe the appearance of the 40 kDa intermediate,the W6/32 antibody from control cells exposed to LLnL
which persists for 20 min and is completely resistantor BFA. The expected acquisition of partial endo H resis-
to endo H (Figure 5B, lanes 5±8). The mobility of thetance is observed for untreated cells at 20 min of chase
intermediate is indistinguishable from that seen for endo(Figure 5A, compare lanes 2 and 4) and for LLnL-treated
H±digested free heavy chains from control cells (Figurecells (Figure 5A, compare lanes 6 and 8); the reduction
5B, lanes 9±12). We conclude that the breakdown inter-in total amount of W6/32 reactive complexes may again
mediate that transiently accumulates in LLnL-treatedbe attributable to reduction in peptide pools available
US111 cells contains little if any N-linked glycans.for assembly (Rock et al., 1994). As expected, treatment
with BFA at these relatively early chase points results
N-Linked Glycans Are Removed from Class I
Molecules in US111 Cells by an N-Glycanase
Type Activity
A pulse-chase experiment performed on US111 cells in
the absence or presence of LLnL establishes the precur-
sor product relationship of the 43 and 40 kDa forms
(Figure 6, lanes 1±14). Even though LLnL slows down
proteolysis, it cannot prevent it: by 40 min of chase,
most of the heavy chains synthesized in the 45 s pulse
have disappeared (lane 14).Figure 4. b2m Is Secreted by US111 Cells in the Absence and Pres-
ence of LLnL SDS±polyacrylamide gel electrophoresis (SDS±PAGE)
fails to distinguish between class I heavy chains degly-Cells were labeled with [35S]methionine for 30 min. Supernatants
were collected immediately after the labeling andafter 60 min chase. cosylated using endo H and class I heavy chains isolated
The US111 cells were preincubated in methionine-free medium with- from tunicamycin (TM)-treated cells (Figure 6A, lanes 16
out (minus) or with LLnL for 1 hr. The controlcells were preincubated and 17); these differ by the presence of a single GlcNAc
in methionine-free medium. The b2m protein was immunoprecipi-
residue. We considered the possibility of an N-glyca-tated from the supernatants using the monoclonal antibody BBM.1
nase-type reaction, in which the N-glycosidic bond isand, after separation on a 12.5% SDS polyacrylamide gel, visualized
by fluorography. hydrolyzed, and the Asn sidechain is converted to an
ER to Cytosol Dislocation of Class I Heavy Chains
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Figure 6. N-Linked Glycans Are Removed
from Class I Molecules in US111 Cells by an
N-Glycanase Type Activity
(A) The precursor-product relationship of the
43 kDa heavy chain and the 40 kDa break-
down intermediate was established in a 1 min
pulse-chase experiment performed with
US111 cells in the absence (minus) or pres-
ence of LLnL. Class I heavy chains were pre-
cipitated with rabbit anti±heavy chain serum
and separated by SDS±PAGE. The cells were
pulse labeled for 60 s and chased for the
times indicated. Endo H digestion was per-
formed for three samples (untreated cells, 1
min chase; LLnL-treated cells, 1 and 10 min
chase). Samples before and after endo H di-
gestion are shown in lanes 15±21. The class
I heavy chains obtained in the presence of
tunicamycin (TM; lane 17) are devoid of any
carbohydrate.
(B) Isoelectric focusing (IEF) gel loaded in ex-
actly the same order as the SDS±PAGE
shown in (A). Note the shift in isoelectricpoint
from the breakdown intermediate.
(C) US111 and control cells were labeled for
20 min and chased for 0 or 20 min. For US111
cells, LLnL was included in the labeling and chase medium. Class I heavy chains were digested with N-glycanase where indicated. Following
complete denaturation in SDS, heavy chains were reimmunoprecipitated with rabbit anti±heavy chain serum, and analyzed by 1D IEF. In
control cells, digestion of class I heavy chains with N-glycanase shifts the banding pattern to a more acidic position for both the 0 and 20
min time points (brackets; Class I±CHO). In US111 cells, some of the core-glycosylated precursor is observed at the 0 min time point and is
still susceptible to N-glycanase digestion. Note that at the 20 min. timepoint, when only the breakdown intermediate is detectable (see Figure
3), digestion with N-glycanase is without effect on the IEF banding pattern. Moreover, the pattern observed in US111 cells is indistinguishable
from that seen for N-glycanase-digested Class I heavy chains from control cells. The two panels shown are derived from the same electrophoretic
separation, but different exposures were required to compensate for levels of incorporation of label. Cathode is at the top.
Asp residue (reviewed by Tarentino and Plummer, 1994). heavy chains with isoelectric points identical to the
breakdown intermediates seen in LLnL-treated US111Such conversion should result in a change in isoelectric
point of the class I heavy chains. cells, and the breakdown intermediates in US111 cells
are refractory to digestion with N-glycanase (Figure 6C).When the samples shown in Figure 6A are analyzed by
one dimensional isoelectric focusing (IEF), we observe Combined, these data argue strongly in favor of the
breakdown intermediate having lost all N-linked oligo-multiple bands in the anti±heavy chain precipitates. This
multiplicity of bands is due to the simultaneous pres- saccharides in an N-glycanase catalyzed reaction, the
polypeptide backbone remaining intact.ence of the products of HLA-A, -B, and -C loci, each
with a unique isoelectric point (Neefjes et al., 1986). Most
of the class I heavy chains have isoelectric points well The Absence of N-Linked Glycans Does Not
above the pKa of sialic acids or protein-bound phos- Affect Breakdown of Class I Heavy Chains
phate moieties (Eichholtz et al., 1992). For each of the in US111 Cells
isoelectric species present at the beginning of the TM treatment of control cells produces the expected
chase, the breakdown intermediate seen in LLnL- nonglycosylated heavy chains that are stable during the
treated cells at later time points migrates at a more 20 min chase (Figure 7A, compare lanes 1 and 2 with 3
acidic isoelectric point (compare Figures 6A and 6B, and 4). In US111 cells exposed to TM, breakdown of
lanes 1±7 and 8±14). Based on previous observations class I molecules proceeds as it does in untreated US111
(Eichholtz et al., 1992) this change in isoelectric point cells (Figure 7A, compare lanes 5 and 6 with 7 and 8).
is of a magnitude comparable to that seen for addition Inclusion of LLnL allows the visualization of the 40 kDa
of a single sialic acid residue and thus most likely corre- intermediate (Figure 7B, lanes 9±12), and there is no
sponds to the conversion of the amide (Asn) to the acid difference inmobility betweenprecursor and breakdown
(Asp). For comparison, we have included class I mole- intermediate in LLnL-exposed, TM-treated cells (Figure
cules isolated from TM-treated cells (Figure 6, lane 17). 7B, lanes 11 and 12). The increased survival of the break-
In TM-treated cells glycosylation is suppressed, and the down intermediate in TM-treated cells exposed to LLnL
acceptor Asn residues persist as such without affecting may be deduced from a comparison of lanes 9 and 10
isoelectric point. The presence of the single remaining with 11 and 12 (Figure 7B) and is no less than that
GlcNAc residue as produced by digestion with endo H observed when comparing lanes 1 and 2 with 3 and 4
should not affect the isoelectric point of the class I heavy (US111 cells labeled in the absence of TM). The shift in
chains either, and indeed yields digestion products in- mobility seen for US11 in TM-treated cells is consistent
distinguishable in focusing pattern from class I heavy with the predicted presence of a single N-linked glycan.
chains isolated from TM-treated cells (compare lanes Note that US11, in both glycosylated and nonglycosy-
lated form, is stable over the chase period during which15±17). In vitro treatment of core-glycosylated class I
heavy chains with peptide N-glycanase yields class I class I heavy chains are degraded.
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was described as a very potent inhibitor of proteasomes
(Rock et al., 1994). We synthesized this compound using
solution chemistry and found it to produce a class I
breakdown intermediate indistinguishable from that
produced in the presence of LLnL (Figure 7B, compare
lanes 3 and 4 with 5 and 6). The antibiotic lactacystin
(Fenteany et al.,1995) is perhapsthe most specific inhib-
itor of proteasomes discovered yet: radioactive lacta-
cystin labels only the b-type subunit of proteasomes,
and the compound is strongly inhibitory on proteasomal
proteolysis (Fenteany et al., 1995). Lactacystin, like LLnL
and Cbz-LLL, produces the 40 kDa breakdown interme-
diate (Figure 7B, lanes 7 and 8). We conclude that the
specificity profile of inhibition indicates the involvement
of proteasomes in the destruction of class Iheavy chains
in US111 cells.
Subcellular Fractionation Shows Dislocation
of the Class I Heavy Chain from the
Microsomal Fraction to the Cytosol
Subcellular fractionation experiments were performed
on control cells and US111 cells labeled in the presence
of LLnL, as described in the Experimental Procedures.
For both control and US111 cells, the 1000 g pellet
Figure 7. US11-Mediated Breakdown of Class I Molecules Does (Figure 8, lanes 1 and 2) contains substantial amounts
Not Require N-Linked Glycans, and Is Delayed by Inhibitors of the
of class I heavy chains, b2m, calnexin, and transferrinProteosome
receptor (TfR). This pellet may contain unbroken cells,(A) Control cells (C) and US111 cells were incubated in methionine-
and larger cellular debris that may also trap solublefree medium without or with tunicamycin (TM) for 1 hr. Cells were
proteins. We therefore consider the distribution of thelabeled for 15 min and chased for 20 min. Immunoprecipitations
were performed with rabbit anti±heavy chain serum and with a rabbit proteins of interest over the 10,000 and 100,000 g pellets
serum against the US11 glycoprotein as indicated. The proteins and the 100,000 g supernatant to be the more significant
were separated on a 12.5% polyacrylamide gel and visualized by parameters. In US111 cells, both intact heavy chains
fluorography. For control cells b2m is visible near the dye front. and some of the breakdown intermediates are present
(B) US111 cells were pretreated with LLnL, Cbz-LLL, lactacystin,
(Figure 8A, US111, lanes 1 and 2). Whereas in controltunicamycin, or both LLnL and tunicamycin for 1 hr. Cells were
cells almost all class I heavy chains were recovered inlabeled for 15 min and chased for 45 min in the continued presence
of the inhibitors. The class I molecules were immunoprecipitated the 1000 and 10,000 g pellets (Figure 8A, Control, lanes
using the rabbit anti±heavy chain serum. The relevant section of the 1±4) and no class I heavy chains were detectable in the
autoradiogram is shown. 100,000 g supernate (Figure 8A, Control, lanes 7 and
8), the breakdown intermediate seen in LLnL-treated
Because in all likelihood there exist considerable US111 cells was largely recovered from the 100,000 g
pools of preexisting fully glycosylated US11 molecules supernate (Figure 8A, US111, lanes 7 and 8). We there-
when TM treatment and labeling are initiated, we cannot fore conclude that US11 mediates the transfer of the
conclude that nonglycosylated US11 is still biologically class I heavy chain from the ER environment to the
active; but clearly, nonglycosylated class I molecules cytosolic compartment. In the same subcellular frac-
are fully susceptible to degradation imposed by the tions, the light chain b2m that is not associated with
presence of the US11 product. class I heavy chains (no coprecipitating heavy chains
were observed; data not shown) sediments predomi-
The Proteasome Inhibitors Carboxybenzyl-Leucyl- nantly with the microsomal fractions, and its distribution
Leucyl-Leucinal and Lactacystin Produce is not noticeably different for control cells and US111
a Class I Breakdown Intermediate cells (Figure 8B). The intracellular compartments that
Indistinguishable from that Seen contain b2m must therefore remain largely intact in the
in LLnL-Treated Cells course of homogenization. This finding also argues
Peptide aldehydes such as LLnL have been widely used against breakage of intracellular organelles as the
as inhibitors of proteases (Sherwood et al., 1993; Rock source of the soluble class I breakdown intermediate in
et al., 1994). Their precise target of inhibition is often US111 cells, and supports its cytosolic localization.Note
difficult to assess, and the rank order of inhibitory po- that recovery of the class I breakdown intermediate us-
tency on purified proteases derived from different ing anti±heavy chain serum did not require the inclusion
sources, such as lysosomal or proteasomal, has been of detergent.
used as a criterion for identification of their intracellular The distribution of US11 itself is indicative of a micro-
targets (Rock et al., 1994). For example, whereas LLnL somal localization. Of note, the class I breakdown inter-
has been described as a calpain I inhibitor, it is known mediate (Figure 8A, US111) is found in a compartment,
to inhibit other proteases, including lysosomal prote- the 100,000 g supernate, that is entirely devoid of US11
ases and the proteasome (Rock et al., 1994). The com- (Figure 8C, US111, lanes 7 and 8). Therefore, at the time
that the breakdown intermediate has been generated,pound carboxybenzyl-leucyl-leucyl-leucinal (Cbz-LLL)
ER to Cytosol Dislocation of Class I Heavy Chains
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the immune system through down-regulation of MHC
class Imolecules. In this regard,human cytomegalovirus
has been an enigma: in HCMV-infected cells, there is a
strong reduction in the cell surface display of host class
I molecules, yet the gene(s) responsible, let alone the
mechanism(s) by which this is accomplished, have re-
mained obscure until recently.
A systematic search of the HCMV genome revealed
the US11 gene as a major determinant of class I instabil-
ity (Jones et al., 1995). With respect to class I heavy
chain turnover, cell lines transfected with US11 behave
in the same manner as HCMV-infected cells. Pulse-
chase analysis revealed that all of the class I heavy
chains synthesized in a 45 to 60 s pulse were broken
down with an initial t1¤2 of <1 min. The occurrence of a
core-glycosylated precursor to the breakdown interme-
diate in US111 cells shows that initial insertion of Class
I heavy chains into the ER takes place normally. Poly-
peptide chain elongation proceeds at a rate of some 4
amino acids per second (Braakman et al., 1991), and
thus the time required for completion of a 338-residue
class I heavy chain (excluding signal peptide) would take
z80 s. Destruction of class I molecules in US111 cells
is a process that most likely starts as soon as the poly-
peptide chain is completed, and must target molecules
located in the endoplasmic reticulum, to which US11
itself is confined. No breakdown intermediates could be
visualized unless protease inhibitors were included in
the labeling and chase medium. An unexpected obser-
vation was the identity of a deglycosylated intermediate,
the product of an N-glycanase-catalyzed reaction, that
transiently accumulated in LLnL-treated US111 cells.
The N-linked glycan itself plays no role in targeting class
I heavy chains for destruction.
The specificity of the breakdown process deserves
comment. US111 cells show no apparent growth disad-
vantage in tissue culture, suggesting that even if multiple
substrates werebeing attacked by this US11-dependent
process, no functions essential for growth are compro-
mised. As examples, neither transferrin receptors nor
calnexin are affected in their biosynthesis or intracellularFigure 8. In US111 Cells, Treated with LLnL, Most Class I Heavy
Chains Are Present in the Cytosol distribution by the presence of US11. We favor the no-
tion that specific breakdown of class I heavy chainsSubcellular fractionation on US111 and control cells was performed
as described in the Experimental Procedures. Class I heavy chains is the consequence of their selective transfer to the
were precipitated from the subcellular fractions using the rabbit cytosol.
anti±heavy chain serum (A). Note recovery of the breakdown inter- There are at least three arguments in favor of the
mediate from the 100,000 g supernatant. The b2m molecules were
cytosolic disposition of the class I heavy chain break-immunoprecipitated using the monoclonal antibody BBM.1 (B). The
down intermediate. First is the occurrence of thenongly-US11 glycoprotein could be recovered from US111 but not from
control cells (C). Note that US11 sediments largely with the micro- cosylated intermediate: in mammalian cells, N-glyca-
somal fractions and is absent from the 100,000 g supernatant, the nase has been reported as a cytosolic activity (Suzuki
compartment that contains the heavy chain breakdown intermedi- et al., 1994). While the published data are by no means
ate. Calnexin (D) and transferrin receptor (TfR; [E]) were immunopre- conclusive, localization of N-glycanase to the ER would
cipitated using the monoclonal antibodies AF8 and 66Ig10, respec-
seem less plausible. It would entail the risk of inappropri-tively.
ately removing glycans from nascent or newly synthe-
sized glycoproteins, which may depend on these gly-
there can be no physical interaction between US11 and cans for entering the proper folding or sorting pathway
this intermediate. As further controls, we show that nei- (Hammond et al., 1994; Scheiffele et al., 1995). Is the
ther calnexin (Figure 8D), nor TfR (Figure 8E) are recov- presence of an N-linked glycan on the class I heavy
ered from the 100,000 g supernatant. chain incompatible with its re-entry into the cytosol via
the translocation complex by which it entered the ER?
Discussion The physical dimensions of the pore involved in translo-
cation are not known (Simon and Blobel, 1991), but at
The present study reveals yetanother astonishing exam- least in bacteria, which possess a homologous translo-
cation complex, nascent chains are accompanied intople of how virus-infected cells may evade detection by
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the pore by a second polypeptide, the SecA protein, proteins in the course of translocation. This would be
analogous to the function of the mitochondrial matrixwhich transiently acquires a transmembrane orientation
(Economou and Wickner, 1994; Kim et al., 1994). If two Kar2 homolog, HSP70 (Schneider et al., 1994). It is at
this stage that US11 could interfere with the interactionspolypeptide chains can be accomodated simultane-
ously by the translocation complex, we see no obvious between class I heavy chains and the molecular ratchet.
Having failed to properly engage this ratchet, for exam-impediment to transport of a glycosylated polypeptide
backbone out of the ER. ple because US11 and the Kar2 equivalent bind to the
same key site, the class I molecule may slide back intoSecond is the ability of a number of protease inhibitors
to interfere with the breakdown of class I molecules. the cytosol after completion of the polypeptide chain.
However, Kar2/BiP did not appear to be required forThese inhibitors are the peptide aldehydes LLnL and
CbzLLL, the latter of which was reported to show strong the cotranslational mode of translocation (GoÈ rlich et al.,
1992; GoÈ rlich and Rapoport, 1993; Panzner et al., 1995),preference for inhibition of proteasomal proteolysis, at
least in vitro. More convincingly, lactacystin, the only and further experiments will be required to distinguish
between the possibilities suggested here.active site-directed inhibitor selective for the proteaso-
mal b-type subunits (Fenteanyet al., 1995), also inhibited Little is known about the pathways in normal cells
that lead to destruction of MHC class I molecules, espe-class I breakdown and produced the nonglycosylated
intermediate. Unless we assume the presence of a hith- cially of their intra membrane and cytoplasmic portions.
Presumably, the lumenal segments are readily degradederto undiscovered proteolytic activity in the lumen of
the ER that is also a target of inhibition for lactacystin, we when they enter the final part of the endocytic pathway,
where the environment is reducing and where the lowconsider this strong evidence in support of proteasome-
mediated, and hence a cytosolic location for, US11- pH and abundant proteases finish them off. Indeed, for
class I molecules that have exceeded their useful lifestimulated breakdown of class I molecules.
Third, the sedimentation behavior of class I molecules span at the cell surface, destruction is preceded by loss
of bound peptide and b2m (not necessarily in that order)is altered dramatically in cells that express US11.
Whereas in normal cells all class I heavy chains as well (Neefjes et al., 1993), and can be blocked to a significant
extent through inactivation of the vacuolar proton-as other membrane proteins (TfR, calnexin, and US11
itself) sediment after 1 hr at 100,000 g, most of the 40 pumping ATPase by the macrolide antibiotic concana-
mycin B (R. Machold and H.L.P., unpublished data).kDa nonglycosylated breakdown intermediates fail to
do so under these conditions and are therefore cytosolic Other type I membrane proteins may follow a similar
general scheme for their catabolism. The involvementby definition (Lardy, 1965).
Current models suggest that, upon arrival of a so- of proteasomes in the breakdown of the cystic fibrosis
transmembrane conductance regulator (CFTR) proteincalled stop-transfer signal, type I membrane proteins
anchor themselves firmly in the lipid bilayer by lateral was recently suggested, based on the inhibitory effects
of Cbz-LLL and lactacystin, as well as the occurrencediffusion out of the protein complex that mediates their
cotranslational insertion (Simon and Blobel, 1991). The of ubiquitinated breakdown intermediates (Jensen et al.,
1995; Ward et al., 1995). It should be noted that theUS11 product may allow newly synthesized class Imole-
cules to exit the ER for the cytosol in a reaction that mature form of the CFTR has some 80% of its total
mass exposed on the cytosolic face, and that aberrantlyrepresents a reversal of the insertion process, by inter-
ference with the reception of this stop-transfer signal. folded CFTR decays with a t1¤2 of some 30 min. In the
case of CFTR, there is no evidence that its membraneUpon termination of the polypeptide chain the ribosome
dissociates from the translocation complex. A failure to topology is altered prior to attack by cytosolic pro-
teases.properly exit the translocation complex might allow the
polypeptide chain to move in a backward motion to- Clearly, US111 transfectants reveal a novel pathway
that alters the membrane dispostion and fate of a typewards the cytosol. Access of the newly synthesized
class I heavy chain to cytosolic proteases or other pro- I membrane protein. These findings have implications
not only for our understanding of the biology of HCMV,teins will likewise require the dissociation of the ribo-
some. In this model, a specific but transient interaction but also for the biosynthesis and turnover of membrane
proteins in general. Viruses have withstood the selectiveof the lumenal domains of US11 and class I ensures
that only class I molecules, and not other membrane or pressures exerted by the host environment through
clever exploitation and evasion of cellular mechanisms,secretory proteins, would suffer this fate. Any class I
heavy chain that finds itself fullyexposed to the cytosolic and have had tens of millions of years to hone these
strategies. As far as class I expression is concerned,environment would be broken down rapidly, as are other
type I membrane proteins inappropriately expressed in we refer to the recent finding (FruÈ h et al., 1995; Hill et al.,
1995) that HSV comes equipped with a potent inhibitor ofthe cytosol (Townsend and Bodmer, 1989).
An alternative interpretation invokes the involvement the MHC-encoded peptide transporter, the TAP com-
plex, thus thwarting presentation of viral antigen at aof Kar2 or Bip-equivalents. The Kar2 protein in yeast is
needed for efficient posttranslational translocation into crucial step in the virus' lifecycle. Every single step in
the biogenesis and intracellular transport of class I mole-the ER of secretory and membrane proteins in vivo and
in vitro (Vogel et al., 1990; Sanders et al., 1992; Panzner cules is a potential target for these stealth strategies.
The present example of US11 shows that this small typeet al., 1995). Its mechanism of action may involve re-
peated cycles of interaction and disengagement to pro- I membrane glycoprotein may accomplish the elimina-
tion of MHC class I products by effectively redirectingduce a ªpullingº action via a molecular ratchet, allowing
entry and blocking slippage back into the cytosol of the class I heavy chain to the proteolytic machinery of
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recrystallized from ethanol/water. Next, Leucinol (Advanced Chem-the cytosol. But these findings also raise the question
tech) was coupled to Cbz-Leu-Leu using standard HoBt, DIC cou-whether degradation of membrane proteins in the ER
pling in dioxane. The crude Cbz-Leu-Leu-Leucinol was purified bymay not more generally avail itself of this possibility.
flash chromatography in methylene chloride/methanol 12:1 (v:v).
The carbohydrate moieties of membrane glycoproteins Finally, Cbz-LLL was synthesized by oxidation of the corresponding
degraded prior to their leaving the ER fail to enter the alcohol using the Swern method. In brief, the tripeptide alcohol was
dried and dissolved in methylene chloride. To an argon-flushed flasksecretory pathway, and instead may be broken down
cooled to 2788C was added oxalyl chloride and dimethyl sulfoxidein the cytosol (Moore and Spiro, 1994). We suggest as
in methylene chloride. After 10 min, the peptide alcohol was added.a more general possibility that misfolded membrane pro-
Finally, the reaction was quenched with triethylamine and allowedteins may be dislocated from the ER and be degraded
to warm to room temperature. Water was added and the resulting
by proteases in the cytosol, and not necessarily by pro- crude aldehyde was extracted with three portions of methylene
teases in the lumen of the ER. To sequester proteases chloride. Pure Cbz-LLL was obtained by flash chromatography of
the organic phase in methylene chloride/methanol 30:1. The purityfrom the environment into which proteins are inserted
and identity of the peptide aldehyde as well as intermediates inbiosynthetically would prevent exposure of incom-
the synthesis were characterized by thin-layer chromatography andpletely folded proteins to the risk of proteolytic damage.
nuclear magnetic resonance spectroscopy. Cbz-LLL was dissolvedWhile we do not wish to suggest that the breakdown of
in ethanol and used at a final concentration of 20 mM.
ER-resident misfolded membrane proteins must obliga-
torily take place in the cytosol, the results presented Pulse-Chase Analysis
here show that this route is in principle open in the Cells were detached by trypsin treatment and incubated in methio-
nine-free Dulbecco's modified Eagle's medium with or withoutmammalian cell, has been exploited by human cytomeg-
added inhibitors for 1 hr. Two million cells (15 min pulse; 250 mCialovirus, and is unlikely to be restricted to that single
of label) or 5 3 106 cells (45±60 s; 500 mCi of label) were used perexample. If one considers antigen presentation by MHC
sample. Incorporation was terminated by the addition of nonradio-
class I proteins as a process in essence focused on active methionine to a final concentration of 1 mM. Immediately
cytosolic proteins, our results would immediately sug- after the chase, samples were placed on ice and lysed in 1 ml of
gest mechanismsby which peptides, derived from lume- ice-cold NP40 lysis mix. Preparation of lysates and immunoprecipi-
tations were performed as described (Beersma et al., 1993).nally disposed proteins, may be generated by the cyto-
solic protease machinery and delivered to class I
Gel Electrophoresismolecules by the MHC-encoded peptide transporter.
SDS±PAGE, one-dimensional IEF, and fluorography were performed
as described (Ploegh, 1995).
Experimental Procedures
Subcellular Fractionation
Cells and Cell Culture Cells (n 5 108) were incubated in methionine-free medium with LLnL
U373-MG astrocytoma cells and US11 transfectants prepared from for 1 hr. Cells were then labeled with [35S]methionine (250 mCi/ml)
this cell line have been described (Jones et al. 1994, 1995; Kim et in a volume of 2 ml for 15 min. The cells were washed in homogeniza-
al., 1995). The cells were cultured in Dulbecco's modified Eagle's tion buffer (0.25 M sucrose, 10 mM triethanolamine, 10 mM acetic
medium supplemented with 5% (v/v) fetal calf serum and puromycin acid, 1 mM EDTA [pH 7.4] and the protease inhibitors leupeptin [1
(Sigma, St. Louis, MO) at a final concentration of 0.375 mg/ml.
mM], iodoacetamide [50 mM], phenylmethylsulfonyl fluoride [1 mM],
and LLnL [20mM]) and resuspended in 2 ml of homogenization buffer.
Antibodies Cells were homogenized on ice using a Dounce homogenizer (30
For studying assembly of class I molecules, the mouse monoclonal or 50 strokes) with a tight fitting pestle (Thomas, pestle type A). The
antibody W6/32,specific forassembled class I molecules, the mono- homogenate was spun at 1,000 g for 10 min, which yielded the 1,000
clonal antibody BBM.1 recognizing both free b2m and class I heavy g pellet. The supernatant was subjected to 10,000 g centrifugation
chain±associated b2m, and the rabbit anti±class I heavy chain serum for 30 min, which yielded the 10,000 g pellet. Finally, the 10,000 g
were used (see Beersma et al., 1993). The monoclonal antibody supernantant was spun at 100,000 g for 1 hr, which resulted in the
66Ig10 recognizing the human transferrin receptor was used for 100,000 g pellet and the 100,000 g supernatant (cytosol). Lysis mix
isolation of TfR, as described (Beersma et al., 1993). Polyclonal was added to all pellets (but not to the 100,000 g supernatant) and
rabbit serum reactive with US11 was described previously (Jones immunoprecipitations, SDS±PAGE, and fluorography were per-
et al., 1991). formed as described.
Biochemical Methods and Materials Immunoelectron Microscopy
Leucyl-leucyl-norleucinal (LLnL; Boehringer Mannheim, Germany) U373 cells expressing US11 and control transfected cells were
was dissolved in ethanol and used at a final concentration of 50 treated with LLnL as above, or taken directly and processed for
mM. TM and brefeldin A were from Sigma (Sigma Chemical Co., St. immunoelectron microscopy as described (Slot et al., 1991; Liou
Louis). Treatment with endoglycosidase H (Endo H; New England and Slot, 1994) using rabbit anti-US11 antiserum and labeled with
Biolabs, Beverly) or N-glycanase (Boehringer Mannheim, Germany) 10 nm protein A±gold particles.Sections were contrasted with uranyl
were performed as suggested by the manufacturers. Lactacystin and embedded in a mixture of methyl cellulose and uranyl as de-
(Fenteany et al., 1995) was used at a final concentration of 20 mM. scribed (Liou and Slot, 1994).
[35S]methionine (1200 Ci/mmol) was from NEN±Du Pont.
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